CISTIM, Belgium

Tasks in the project:
CISTIM will contribute to work packages 1,3,4,5 and 6
WP1 : Cell culture-based discovery of antiviral inhibitors and their mechanism of action
WP3 : Target-directed discovery of antivirals
WP4 : ADME-Tox and validation in animal models
WP5 : Exploitation and route-to-market
WP6 : Coordination

  Human resources

  • Dr. P. Chaltin, PhD, PI, (M), expertise in small molecule drug discovery projects and IP, especially the overall management thereof and the medicinal chemistry aspects thereof; (6 PMs)
  • Dr Arnaud Marchand, Director of Medicinal Chemistry: supervision of project (6 PMs)
  • One medicinal chemist Ph.D, with expertise in performing organic synthesis for the prep aration of potential new drugs (medicinally relevant compounds); (24 PMs)

13 Minderbroederstraat,
3000 Leuven, Belgium.
Tél: +3216332961. Fax: +32-16-332968.

The research leading to these results has received funding from the European Union Seventh Programme (FP7 2007/2013) under grant agreement n°260644-SILVER